O
0.022
0.00 (-4.35%)
| Previous Close | 0.023 |
| Open | 0.023 |
| Volume | 203,348 |
| Avg. Volume (3M) | 192,135 |
| Market Cap | 5,169,296 |
| Price / Sales | 24.05 |
| Price / Book | 133.28 |
| 52 Weeks Range | |
| Earnings Date | 29 Jul 2025 - 4 Aug 2025 |
| Operating Margin (TTM) | -1,523.76% |
| Diluted EPS (TTM) | -0.010 |
| Quarterly Revenue Growth (YOY) | -82.70% |
| Current Ratio (MRQ) | 0.520 |
| Operating Cash Flow (TTM) | -2.10 M |
| Levered Free Cash Flow (TTM) | -1.18 M |
| Return on Assets (TTM) | -296.24% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (AU) | Mixed | Mixed |
| Health Information Services (Global) | Bearish | Mixed | |
| Stock | OPYLLIMITD FPO [OPL] | - | - |
AIStockmoo Score
0.1
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 0.0 |
| Average | 0.13 |
|
Opyl Ltd is engaged in the development of its digital tools that improve clinical trials, healthcare experience for patients, deliver deep market insights from social media data, and improve the efficiency and value of the clinical research process. It invests in research and develops technologies as well as provides digital tools and insights services to healthcare, wellness, and science technology-focused clients. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Value |
| % Held by Insiders | 63.16% |
| % Held by Institutions | 4.89% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |